SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1483)10/19/1998 9:16:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Walter,
The PMC deal is not in Cistron's stock price until you get past the 50 cent level...Current market value 22 cent a share.

The total value of the PMC deal in the Letter of Intent if all of the milestones are meet would mean another $1.43 a share in value to Cistron.

The deal is obviously not in Cistron's current price of 22 cents.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News